State of Tennessee, Department of Treasury
SMMT icon

State of Tennessee, Department of Treasury’s Summit Therapeutics SMMT Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,501
Closed -$17K – 1518
2017
Q4 		$17K Hold
1,501
– – ﹤0.01% 1511
2017
Q3 		$19K Hold
1,501
– – ﹤0.01% 1471
2017
Q2 		$17K Sell
1,501
-733
-33% -$8.25K ﹤0.01% 1494
2017
Q1 		$30K Buy
+2,234
New +$25.8K ﹤0.01% 1497

Other funds holding SMMT

LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

State of Tennessee, Department of Treasury's SMMT Position: Q1 2018 in Review

State of Tennessee, Department of Treasury sold out of Summit Therapeutics (SMMT) in Q1 2018, closing a stake of 1,501 shares — an estimated $17K sold.

State of Tennessee, Department of Treasury first reported a position in SMMT in Q1 2017 and held it in 4 quarters. The position peaked at $30K in Q1 2017. 20 funds tracked by Wall St. Rank hold SMMT as of Q1 2018.

  • State of Tennessee, Department of Treasury reported no remaining Summit Therapeutics position as of Q1 2018 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 1,501 Summit Therapeutics shares in Q1 2018, an estimated $17K.
  • State of Tennessee, Department of Treasury first reported a position in Summit Therapeutics in Q1 2017 and held it in 4 quarters.
  • State of Tennessee, Department of Treasury's Summit Therapeutics position peaked at $30K in Q1 2017.
  • 20 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2018.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2018, filed 11 May 2018.